Tweet
Share
Myworld |
Sign Up
|
Login
Home
Browse
Featured
Latest
Popular
Templates
Patients
Blog
Infective endocarditis
×
Send This
Download
Comment
Favourite
more
Add to your Conference/Group
Please Select--
Add your comments:
Insert YouTube Videos inside your Slideworld presentation Copy and paste the video URL from YouTube, choose where to insert the video, and press “Submit”. The video will play in your slideshow after sometime.
Enter YouTube video URL
Enter Slide No where you want to insert youtube videos
Rating :
Rate It:
Embed :
Post a comment
Post Comment on Twitter
Post Comment on SlideWorld
Comments:
Subscribe to follow-up comments
SlideWorld will not store your password. SlideWorld will maintain your privacy.
Twitter Username:
Twitter Password:
Comments:
Email:
Subscribe to follow-up comments
Notes
Show Notes
Hide Notes
Slide 1 :
Epidemiology, Clinical Characteristics and Evolution of Infective Endocarditis in Under-developed Countries: Results of the Argentinian Registries (EIRA) Dr J Horacio Casabé MD, PhD , FACC, MTSAC Fundación Favaloro, Buenos Aires, Argentina World Congress of Cardiology May 18-21 2008 Buenos Aires, Argentina Nothing to disclose
Slide 2 :
The first National survey of IE in Argentina (EIRA-1) was conducted between 1992 and 1993 EIRA Studies Background It was the first multicenter survey done in an underdeveloped country and was published in the Revista Argentina de Cardiologia JH Casabé, CD Pellegrini, AR Hershson, MS Ramos, L Vidal, EA Sampó JL Barisani, L Clara, EA Argüello y SD Varini.Endocarditis Infecciosa en la Republica Argentina. Resultados generales. Rev Argent Cardiol 1996; (Suplemento V):9-19.
Slide 3 :
EIRA 1
Slide 4 :
Multicenter study (33) with 294 episodes in 285 patients according to Duke Criteria included in 18 months 55% had underlying heart disease 63.3% predisposing event ;40 cases (13%)of drug abuse 23,5 % of Hospital Mortality EIRA 1
Slide 5 :
EIRA 1 Symptoms EIRA 1 Symptoms
Slide 6 :
EIRA 1 Signs EIRA 1 Signs
Slide 7 :
EIRA 1 IV Drug abuse patients Rev Argent Cardiol 1996;64: 27-32
Slide 8 :
EIRA 1 IV Drug abuse patients Rev Argent Cardiol 1996;64: 27-32
Slide 9 :
EIRA 1 IV Drug abuse patients Rev Argent Cardiol 1996;64: 27-32
Slide 10 :
Surgical Treatment EIRA 1
Slide 11 :
After 10 years, in 2002-2003 with the objective of determine the epidemiologic, clinical, microbiologic characteristics, and inhospital outcome of IE in Argentina and compare the results with the 1992 IE national survey ,the Argentinian Society of Cardiology (SAC) decided to do a new multicenter Survey: the EIRA 2 study EIRA Studies Rational
Slide 12 :
Am Heart J 2006;151:545-52
Slide 13 :
EIRA 2. Representativity Euro Heart Survey159 cases in 92 centres from 25 countries in 1 year (Heart 2005) French Registry : 26% territory of France, 290 patients (JAMA 2002) International Collaboration on Endocarditis Group(ICE) 1779 EI definite patients during 4 years in 39 centres from16 countries.Average: 111 cases/country/4 years or 28 cases/country/year (JAMA 2005) Endocarditis Infecciosa en la República Argentina(EIRA 2) . > 75% national territory. Average : 260 cases/year (Am Heart J 2006)
Slide 14 :
EIRA-1 EIRA-2 Nº episodes 294 470 N° Definite IE 75,5% 83,0% Age in years (average) 51,3 58,5* Male sex 69,5% 70,0% Underlying heart disease 55% 66,2%* Pathologic confirmation(%) 20,7% 29,2% Diabetes (%) ND 14,6% Previous IE(%) 10,2% 11,3% Previous heart surgery(%) ND 20,8% COPD (%) ND 4,4% Chronic renal failure ND 14,2% EIRA Studies Basal Characteristics * p < 0,01
Slide 15 :
% EIRA Studies Underlying heart disease
Slide 16 :
Microorganisms Negative blood cultures: EIRA 1: 20,4 ; EIRA 2: 17,7% EIRA Studies %
Slide 17 :
Valve involvement % * p < 0,01 * EIRA Studies
Slide 18 :
Time to diagnosis 33,07 ± 34,3 days 21,5 ± 35,3 days p < 0,001 EIRA Studies
Slide 19 :
Evolution: Complications % * p < 0,01 * EIRA Studies
Slide 20 :
Evolution: Surgery and Mortality % p = NS EIRA Studies
Slide 21 :
EIRA Studies S aureus Infective endocarditis
Slide 22 :
% SAIE 108 episodes (30%) vs. NSAIE 282 episodes * p < 0,01 * * * Age SAIE 57,0±17 vs 59,0±17; p = 0,05 EIRA. S aureus Underlying diseases
Slide 23 :
EIRA. S aureus Predisposing factors and concomitant diseases % * p < 0,01 * * * *
Slide 24 :
33,3% TTE / 66,6% TTE + TEE EIRA. S aureus Echocardiogram % Vegetation size(mm) SAIE 17,5 ± 10,1 vs NSAIE 12,7 ± 10,7; p=0,03
Slide 25 :
EIRA. S aureus Localization % * p < 0,01 * *
Slide 26 :
EIRA. S aureus IE Evolution: Complications % * p < 0,01 ** p = 0,14 * * * **
Slide 27 :
EIRA. S aureus IE Surgery Indications % * p = 0,001 ** p = NS * ** **
Slide 28 :
EIRA. S aureus Surgery and Mortality % OR 0,6 (IC 95% 0,36-1,2) p=NS OR 2,0 (IC 95% 1,2-3,3) p=0,009
Slide 29 :
Increase of S aureus as etiologic agent
Slide 30 :
Clin Infect Dis 2005;41:507-514 Increase of S aureus as etiologic agent
Slide 31 :
Increase of S aureus as etiologic agent
Slide 32 :
In the last 10 years clinical profile of IE has changed in Argentina Currently patients are older (7 years) and have a higher frequency of underlying heart disease, degenerative valve disease,and prosthetic valve. Intravascular catheters and predisposing factors are more prevalent than previously There is an increase of congenital heart disease and a decrease of rheumatic heart disease as underlying heart disease in the group of patients aged < 40 years . EIRA Studies : Conclusions (1)
Slide 33 :
The incidence of S aureus IE has increased.; it was an inversion in the prevalence(S viridans : S aureus) Patients with S aureus IE have a high risk profile and worse hospital evolution (more embolism, CVA, septic shock and mortality) Despite advances in surgical treatment and earlier time to diagnosis,the incidence of complications and mortality has not been reduced EIRA Studies : Conclusions (2)
Slide 34 :
EIRA Studies : Conclusions (3) One likely explanation for the absence of a positive correlation with better outcome might be the higher risk profile of the EIRA-2 patient (older population, higher prevalence of valve prostheses,increased proportion of staphylococci IE). Hypothesis
Slide 35 :
Participant Provinces: 16 Medical Centers: 146 EIRA Studies Acknowledgments Coordinating Center Mario Ciruzzi, Ernesto Ferreirós, Sandra Swieszkowski, Juan Carlos Modenesi, Francisco Nacinovich, José H. Casabé y Sergio Varini. Regional Coordinators Hernán Cohen Arazi, Adriana Angel, Cecilia Zevallos, Lucía Kazelian, Claudia Cortés, Román Cragnolino, Mariano Falconi, Alejandra Francesia, Mariano Giorgi, Claudio Higa, Pablo Schygiel, Alejandra von Wulffen.
Slide 36 :
EIRA Studies Thank you for your attention Lago Gutierrez, Bariloche, Argentina
Infective Endocarditis
Infective Encocardit...
Infective Endocarditis
NICE guideline on an...
SUB ACUTE BACTERIAL ...
Infective Pericardia...
Free Powerpoint Templates
jhcasabe@ffavaloro.org
4 Years ago.
5952 Views, 1 favourite
PowerPoint Presentation on Infective endocarditis or PowerPoint Presentation on Epidemiology of Inf
more
PowerPoint Presentation on Infective endocarditis or PowerPoint Presentation on Epidemiology of Infectrive endocarditis
less
More By User
Flag as inappropriate
Select your reason for flagging this presentation as inappropriate. If needed, use the
feedback
form to let us know more details.
None
Pornographic
Defamatory
Illegal/Unlawful
Other Terms Of Service Violation
Copy Right
Cancel
Browse
|
Powerpoint Templates
|
Tags
|
Contact
|
About Us
|
Privacy
|
FAQ
|
Blog
© Slideworld